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Morris).This invited paper reviews the study of protein glycosylation, commonly known as glycoproteomics,
beginning with the origins of the subject area in the early 1970s shortly after mass spectrometry was
ﬁrst applied to protein sequencing. We go on to describe current analytical approaches to glycopro-
teomic analyses, with exemplar projects presented in the form of the complex story of human gly-
codelin and the characterisation of blood group H eptitopes on the O-glycans of gp273 from Unio
elongatulus. Finally, we present an update on the latest progress in the ﬁeld of automated and
semi-automated interpretation and annotation of these data in the form of GlycoWorkBench, a pow-
erful informatics tool that provides valuable assistance in unravelling the complexities of glycopro-
teomic studies.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and historical perspective
Glycoproteomics, as distinct from proteomics or glycomics, is
the study of the glycosylation of proteins, a covalent modiﬁca-
tion which confers altered physico-chemical properties and func-
tional activity on the nascent protein chain. There are two broad
classes of protein glycosylation in nature, those ‘O-linked’ to Ser-
ine or Threonine residues in the protein backbone, and those ‘N-
linked’ to Asparagine residues. Mass spectrometry (MS) has
played a key and irreplaceable role in deﬁning the structures
of glycoproteins over the past 30 years [1,2] using methodschemical Societies. Published by E
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.morris@imperial.ac.uk (H.R.developed from the earlier studies on Antarctic ﬁsh blood ‘‘anti-
freeze” and prothrombin glycoproteins [3,4] together with the
general ‘mass mapping’ strategy [5] of determining and screen-
ing the masses of peptides/glycopeptides produced from speciﬁc
proteolytic or chemical digests, which itself evolved from earlier
‘mixture analysis’ approaches to protein and glycoprotein
sequencing [6,7]. The concept of mapping (sometimes called ﬁn-
gerprinting) derives from the realisation in the late 1970s that
the data set comprised of peptide molecular ions M+ or quasi-
molecular ions [M+H]+ produced by digesting any given protein
is likely to be unique (especially if more than one digest is used),
and therefore it provides a reasonable diagnostic for character-
isation or identiﬁcation of the protein, distinguishing it from
others, importantly without the need for sequencing. From
1981, early research applications of mass mapping ranged from
the screening of recombinant proteins and glycoproteins for
the Biotech industry, detecting errors of translation or conﬁrm-
ing mass matching and thus identity [8] using a software
mass-search aid ProtMap, through to assisting in the structural
characterisation of new peptide hormones [9] and the detection
and characterisation of glycosylation in human Interleukin 2
[10]. With the later advent of comprehensive computerised pro-
tein databases, the peptide maps could then be used to interro-
gate those databases for matches to, and thus identiﬁcation oflsevier B.V. All rights reserved.
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development of the ﬁeld of proteomics.
Two unique strengths of mass mapping were, and still are, the
ability to map (and therefore visualise) the N-terminal and C-ter-
minal domains of a protein with equal probability, and most
importantly, the ability to discover post-translational modiﬁca-
tions (PTMs) including glycosylation by detecting mass shifts in
component peptides in the mass map or by locking on to sugar
mass differences in the map, created by facile glycosidic bond
cleavage. Once detection is achieved in this way, a whole battery
of techniques including tandem mass spectrometry (MS/MS) can
then be applied to determine even the most complex structures,
and this laboratory has reported many such novel glycosylation
studies over the past 20 years including deﬁning the glycosylation
of tissue plasminogen activator [12], of pro-opiomelanocortin
(POMC) [13] of glycodelins A [14] and S [15], cytoplasmic glycosyl-
ation of Skp 1 [16,17], multiple ‘O-linked’ glycosylation of CD8 [18]
and an unexpected novel ‘N-linked’ glycosylation in Campylobacter
jejuni glycoproteins [19].
Despite those advances, the ﬁeld of glycoproteomics remains
a difﬁcult one to enter for the new researcher, largely due to
the sheer complexity and variability in the protein glycosylation
we observe in most areas of biological research. In this paper, we
attempt to demonstrate the further reﬁnement of the strategies
outlined above, with the aim of deﬁning a generic approach to
glycoproteomics, illustrated with advanced studies in which the
interactive informatic tools which we are currently using to as-
sist in detailed interpretation of MS and MS/MS data are
described.
2. Glycoproteomic strategies
A number of reviews have been published which document the
historical perspectives, principles and practice of glycoproteomicFig. 1. A simpliﬁed glycoproteomic experimental workﬂow is shown, illustrating comm
excised from single or multi-dimensional polyacrylamide gels, or batches of cells, ﬂu
categorised as ‘‘top-down” or ‘‘bottom-up”. The former, illustrated by a purple arrow, be
intact molecular weight proﬁle by direct MALDI-TOF MS or by ES-MS. By subtracting
glycosylation may then be deduced. In ‘‘bottom-up” approaches, which incidentally
glycoprotein is digested enzymatically and/or chemically, ideally with high-speciﬁci
spectrometrically either by on-line (red arrows) LC-ES-MS followed by MS/MS analysis of
and MS/MS approaches. Prior to these separation and mapping procedures, various stra
(see text). Parallel glycomic analyses (illustrated by the green arrow) are an invaluable f
glycans followed byMALDI-TOF MS or ES-MS mapping of the glycan populations, usually
their relative amounts, which can then be compared and matched with data at the glycanalysis [1,2,20–25]. The aims of this section are to highlight gen-
eral issues and to suggest where efforts need to be focused to en-
able glycoproteomics research to be carried out more effectively.
Firstly, of course, a key basic requirement is a well-found labora-
tory, for example at Imperial this includes three electrospray (ES)
quadrupole orthogonal acceleration time of ﬂight (Q-TOF) type
instruments (including a Q-Star), 2 matrix-assisted laser desorp-
tion ionisation (MALDI) 4800 time of ﬂight (TOF)–TOFs plus a
range of ancillary equipment, such as gas chromatography (GC)–
MS for composition and linkage analysis and nano-liquid chroma-
tography (LC) for sample presentation both to the Q-TOFs and
TOF–TOFs, in the latter case via a Probot auto-spotter. Broadly
speaking, the majority of laboratories engaged in glycoproteomic
analyses employ all or part of what has become a generic workﬂow
as illustrated in Fig. 1, with speciﬁc methodologies being dictated
by available infrastructure, instrumentation and expertise. The
type of sample being analysed will also inﬂuence the choice of
methodology. For example, although not always applicable to large
and/or highly heterogeneous glycoproteins, molecular weight pro-
ﬁling of intact glycoproteins (purple arrows in Fig. 1) can some-
times provide very useful information on the type and extent of
glycosylation. Such ‘‘top-down” methods have proven especially
powerful, in bacterial glycoproteomics where novel glycans are
frequently observed [26–28], and in studies on intact antibodies
for the Biopharmaceutical industry, where M-Scan routinely
screens intact masses at around 150 kDa by both MALDI-TOF and
ES-Q-TOF to give conﬁrmatory total mass analysis when recon-
structing the detailed protein and carbohydrate proﬁles from mass
mapping studies.
Central to all general glycoproteomic strategies is the mass
spectrometric analysis of glycopeptides, usually after chromato-
graphic separation, either on-line (red arrows) or off-line (blue
arrows), to simplify the maps produced. Glycopeptides are nor-
mally obtained by speciﬁc proteolytic or chemical digestion ofon approaches to glycoproteomic analysis. Samples take the form of slices or spots
ids, immunoprecipitates or tissue extracts. Analytical approaches can broadly be
gins with work on puriﬁed samples of glycoproteins in an attempt to identify the
the known or inferred mass of the protein component, the type and extent of
are essential for describing the detailed glycosylation proﬁle of any protein, the
ty procedures, and the resulting peptide/glycopeptide mixture is mapped mass
signals of interest, or by off-line (blue arrows) strategies involving ES- or MALDI-MS
tegies for enrichment of glycopeptides may be introduced, including lectin binding
eature of the ‘‘bottom-up” approach involving enzymatic or chemical release of the
as permethyl derivatives (see text), providing information about speciﬁc glycans and
opeptide and overall glycoprotein levels.
1730 B. Tissot et al. / FEBS Letters 583 (2009) 1728–1735glycoproteins present in gel bands, immunoprecipitates or tissue
extracts.
‘‘Bottom-up” analysis, as the name suggests, begins with the
analysis of individual glycans, building back through an analyt-
ical tree towards the intact glycoprotein, gathering information
such as glycan structure, glycan repertoire, heterogeneity and
sites of attachment. In the off-line approach, where chromato-
graphic fractions are collected for individual analysis, this is of20 400.0
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Fig. 2. Nano-LC-ES-MS of a tryptic digest of a human glycodelin sample. The sample w
micrograms of the digest products were subjected to on-line reverse-phase nanoLC coup
for a 90-min experiment. Extracted ion chromatograms of glycan fragment ions were us
spectra acquired between 7.5 and 11 min which were identiﬁed as corresponding to a gly
in the low-mass region of the spectrum shown in Panel B. Panels C–E detail portions of th
which have been expanded to show typical patterns for mixtures of multiply charged gly
not labelled but all multiply charged signals can be attributed to glycoforms of two majo
throughout this chapter are those employed by the Consortium for Functional Glycomics
represent N-acetylhexosamines (HexNAc) [yellow: N-acetylgalactosamine (GalNAc),
acetylneuraminic acid (NeuAc).course generally more time-consuming and less suitable to
automation, but it beneﬁts from the fact that one can then
apply a wider array of mass spectrometric equipment and
methods, with far fewer issues than on-line analysis, where
the compatibility of the eluents with mass spectrometric analy-
sis and other limitations arising from the coupling of the chro-
matographic output to the ionisation source may restrict the
applications somewhat.60 80Time (min)
1600 2000)
2000m/z (amu)
1035
3+
0.0
0.36
In
te
ns
ity
(co
un
ts)
16101525 m/z (amu)
2+1541.08
2+1561.61 2+1582.08
E
as reduced, carboxymethylated and dialysed prior to digestion with trypsin. A few
led to a Q-STAR mass spectrometer. Panel A shows the total ion chromatogram (TIC)
ed to determine when glycopeptides elute and Panel B shows the summation of all
copeptide elution time window. The diagnostic glycan fragment ions are annotated
e spectrum with special emphasis at middle mass (Panel D) and high mass (Panel E)
copeptides. For simplicity, the majority of the signals in the complete spectrum are
r peptides containing the same N-glycosylation site at Asn-63. Sugar symbols used
. Circles represent hexoses (Hex) (yellow: Galactose (Gal), green: Mannose), squares
blue: N-acetylglucosamine (GlcNAc)], red triangle: fucose, purple diamond: N-
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also invaluable to glycoproteomic studies, providing information
concerning the speciﬁc glycans present and the relative levels of
the individual structures. Typically, speciﬁc glycan populations
are released by enzymatic and chemical digestion of the peptide/
glycopeptide mixture, derivatised by permethylation in order to
enhance the separation, fragmentation, detection and stability of
the constituent structures and then subjected to mass spectromet-
ric analysis. A variety of enzymatic and chemical digestions of the
released glycans can be employed prior to analysis if more speciﬁc
structural information is desired.
Information gathered from these analytical approaches, the
quantity of which can be vast, can then be used to search for and
identify putative glycopeptides via characteristic fragment ions,
with compositions being assigned through the use of both biosyn-
thetic information and MS and MS/MS data.
Individual glycopeptide glycoforms are often very minor con-
stituents compared with the peptides derived from the proteolytic
digestion. Hence enrichment of glycoproteins and/or glycopeptides
may be essential prior to analysis to ensure that glycoproteomic
information is not obscured by vast quantities of proteomic data.
Lectins [29] and hydrophilic afﬁnity gels [30] are useful tools for
glycoprotein/glycopeptide enrichment. Lectins with relatively
broad speciﬁcity such as concanavalin A (conA), which recognises
high mannose (Man), hybrid and biantennary complex-type N-gly-
cans, are showing considerable promise for enriching serum glyco-
proteins [31], whilst more speciﬁc lectins such as Vicia villosa lectin
(VVL), which preferentially binds to alpha- or beta-linked terminal
GalNAc, are valuable tools for purifying glycoproteins that carry
the cognate structure. For example bovine pregnancy associated
glycoproteins which are rich in glycans carrying the Sda epitope
(NeuAca2-3(GalNAcb1-4)Gal-) can be efﬁciently puriﬁed from pla-
cental tissue using VVL afﬁnity columns [32]. Despite many exam-
ples of successful glycopeptide enrichment, the development of100
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Fig. 3. MALDI-TOF MS proﬁling of Unio elongatulus glycoprotein gp273 O-glycans. Aroun
glycans were removed using PNGase A then separated from the pool of peptides and O
glycans were puriﬁed prior to being permethylated and analysed using MALDI-TOF instr
about possible glycan structures cannot be readily deduced from biosynthetic knowledge.
an unbiased and comprehensive annotation of this MS spectrum. The putative composi
feature of GlycoWorkBench (see text). The type of monosaccharides considered were r
maximum, symbol: blank square), pentose (1 maximum, symbol: blank star), deoxyhe
symbol: blank 2-halved-diamond) and neuraminic acid (1 maximum, symbol: blank diasuch methodologies that are applicable to a wide spectrum of sam-
ples is still a major challenge for glycoproteomics.
An even greater challenge occurs at the end of the workﬂow due
to the paucity of informatic tools that are available to aid data
interpretation (see below). To illustrate the data handling issues
that need to be addressed in glycoproteomic experiments, exem-
plar data from on-line nano-LC-ES-MS analysis of a tryptic digest
of a sample of human Glycodelin [33] are shown in Fig. 2. The
upper panel shows the total ion chromatogram (TIC) for the com-
plete LC–MS run whilst the middle panel shows a summation of
the mass spectra corresponding to the part of the chromatogram
that is highlighted in yellow. This region of the chromatogram
has been chosen for scrutiny because the presence of characteristic
sugar fragment ions (m/z 204, 366, 407 and 512; see annotations in
Fig. 2B) indicate that glycopeptides are present. Putative glycopep-
tide molecular ions are observed at low abundance throughout the
yellow shaded region which is magniﬁed in the bottom panel
(Fig. 2C) for clarity. Parts of the spectrum are expanded in the in-
serts to illustrate the richness of the data and to give insights into
the assignment process (see legend). Interpretation of such com-
plex data is greatly facilitated by prior knowledge of the composi-
tions of the glycans in the glycoprotein sample being studied [33].
For this reason it is often advisable for the glycoproteomic work-
ﬂow to include glycomics experiments which deﬁne the total gly-
can repertoire of the samples under study (see Fig. 1, green arrows)
[21,34,35]. A recent study reporting on the glycoproteome of
mouse uterine luminal ﬂuid [36] is a useful example of how to
optimise the complementarity of the pathways shown in blue,
red and green in Fig. 1 workﬂow.
3. Glycoinformatic tools
Automated identiﬁcation of proteins from MS and MS/MS spec-
tra is now almost routine via the usage of informatic tools such asx 5
3.9e
2303.5 2400.5
1971.3
1881.20.1
1767.1
11 possible compositions
for example:
1x 1x
1x1x
1x 1x1x
1x 2x
1x 1xx
2xx
2x
4x
x 1x1x 5x
1xx 4x
1xx 1x1x1x
2x
2x 1xx 1x 3x
3x 1x2x 1x 4x
3x 3x 3x
3x3x 5x
e (m/z)
       1849.6   2299.8                    2750
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-glycopeptides. The latter were subjected to reductive elimination and reduced O-
umentation. The Unio elongatulus genome is unknown so far. Therefore, information
The use of a semi-automated tool such as GlycoWorkBench proved to be essential for
tions shown in boxes on this ﬁgure have been obtained using the GlycoPeakFinder
estricted to hexose (10 maximum, symbol: blank circle), N-acetylhexosamine (10
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Fig. 4. GlycoWorkBench-annotated MALDI-TOF/TOF MS/MS spectrum of the Unio elongatulus O-glycan species atm/z 912 (panel A) and 1680 (panel B) obtained using MALDI-
TOF/TOF instrumentation. According to the semi-automated annotation performed using GycoPeakFinder the species at m/z 912 and 1680 could correspond to two and six
compositions, respectively. For each of the two MS/MS spectra, a list of fragment ions was manually selected. This list was then compared with the lists of predicted ions
calculated for each of the possible structures corresponding to the computed compositions. A report showing the scores for each proposed arrangement was produced and the
highest score glycan structures are shown on the top right corner of the spectra. Once the structures are selected, GlycoWorkBench can generate annotated spectra as shown
here. For monosaccharide keys, see Fig. 2. The reduced reducing end is represented by the symbol. Keys related to fragmentation are the following: represents a
fragmentation on the reducing end side of the glycosidic bond (also known as B or Z ions) and represents a fragmentation on the non-reducing end side of the glycosidic
bond (also known as C or Y ions).
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ing progress in the glycomics/glycoproteomics ﬁeld is the lack of
rapid, accurate and ﬂexible automated tools capable of retrieving
structural information from MS data. The complexity of the glycan
structures and the variety of techniques that are used for their
study, pose additional obstacles to the development of a single
automated tool that could have the same impact on glycoproteo-
mics as tools such as Mascot have had for proteomics. Library-
based sequencing tools for MS data interpretation, similar to the
methods now commonly used for proteins, are limited by the lack
of availability of comprehensive and well-curated collections of
glycan sequences. De novo sequencing tools and composition anal-
ysis tools are not restricted to previously characterised structures,
but expert knowledge is fundamental to restrict the number of
solutions matching experimental data and to obtain reasonable re-
sults. Probably the most successful of these tools is Cartoonist
which has been designed to incorporate the same assumptions
used by human expert annotators. Information about biosynthetic
pathways is encoded in Cartoonist as a library of several hundred
archetype glycans and a set of rules to modify these structures.
Additional constraints are enforced to further limit the amount of
possible structures. The peaks are then annotated by searching
for all the structures that can be generated from the archetypes
that match the given mass. A software calibration is performed
for each spectrum to match observed and predicted masses. Cali-
bration results together with isotope envelope shapes are then
used to assign conﬁdence scores to peak annotations. Finally, a
graphical output is created by superimposition of the assigned
structures on the actual spectra [37]. The Cartoonist algorithms
continue to be developed with the objective of reducing the
amount of prior expertise required [38]. An additional develop-
ment has been to expand the tool’s use to glycoproteomics. Pep-
toonist now automatically identiﬁes the glycans present at each
N-glycosylation site of a glycoprotein [39]. Similar objectives have
been achieved by combining generated glycopeptide MS/MS data
with in silico workﬂows. These consist of comparing the original
spectra to a N-glycopeptide library to assign the peptide sequence
and predicting the N-glycan composition. Both processes are statis-
tically validated to obtain best ﬁt glycopeptides [40].
One of the major advances in our efﬁciency has come from the
development of GlycoWorkBench. The aim of this tool is to provide
complete support to the routine interpretation of glycomic mass
spectrometric data and to form the basis for the development of
fully automated assignment software. GlycoWorkBench comprises
several features designed to help the user annotate their MS data.
For example, the visual editor of glycan structures, the GlycanBuild-
er [41] enables a rapid assembly of graphical representations of
structural models. Indeed with GlycanBuilder, a glycan can be rap-
idly speciﬁed starting from the reducing end by sequentially add-
ing monosaccharides, modiﬁcations, or reducing-end markers
(for example 2-aminopyridine, 2-aminobenzamide and 2-amino-
benzoic acid) to the already drawn structure, simultaneously com-
puting the corresponding theoretical m/z value. Different possible
chemical derivatisations of the glycan structures, such as perme-
thylation and acetylation, can also be integrated into calculations
of theoretical m/z calculations.
When the structure is too complex and encompasses too many
possible arrangements to be easily drawn, GlycoWorkBench offers
the possibility to the user of entering them/z value of the unknown
species and then deﬁning a set of parameters such as the presence
of chemical modiﬁcation(s), the nature of the reducing end or the
set of possible monosaccharides that could be biosynthetically uti-
lised by the organism studied. These parameters limit the number
of possible arrangements. GlycoWorkBench will then compute the
theoretical m/z values of the various possible compositions, given
the restrictions deﬁned by the user, match them with the experi-mental m/z value and create a report in which compositions are
listed together with the m/z accuracy.
GlycoWorkBench also offers the possibility to assist annotations
of MS/MS data in an interactive manner. Various ways of predict-
ing fragments, from the drawn structures or from given m/z values
are offered to the user. Spectra can also be downloaded and a list of
peaks manually selected. If two possible structures are predicted to
be present, then both can be matched against the list of observed
fragment ions. The in silico fragmentation engine computes a com-
plete list of theoretical fragments (multiple glycosidic cleavages
and all the possible ring fragments). The annotation engine auto-
matically matches the theoretical list of fragment masses with
the manually deﬁned experimental peak-list. The proposed anno-
tations are presented using comprehensive and easily understand-
able reports that allow the comparison of the different annotations
from the structure candidates.
The user can create and maintain multiple sets of candidate
structures, peak-lists, mass spectra and annotated peak-lists in a
single workspace so that all the information generated in an exper-
iment can be organised and stored in a ﬁle. The software is publicly
available for download from the EUROCarbDB Web site [42].
The capabilities of this tool are exempliﬁed by our current gly-
coproteomic studies of a glycoprotein called gp273 which is found
in the extracellular coat of the freshwater mollusc bivalve Unio
elongatulus, and is believed to be the ligand for sperm–egg interac-
tion during fertilisation [43]. This glycoprotein has attracted the
attention of the mammalian developmental biology community
because it has been shown to bind to human sperm and to induce
the acrosomal reaction [44]. Fucosylated epitopes on the O-glycans
of gp273 appear to play a role in this binding. Moreover, it has
been suggested that an anti-gp273 IgG antibody recognises a Lewi-
sa (Galb1-3(Fuca1-4)GlcNAc)-like epitope on gp273. The binding
of human sperm to gp273 was found to be reversed by solubilised
human zona pellucidae [45] suggesting that gp273 might have
structural features in common with the genuine sperm receptor li-
gands on human eggs whose identities remain a mystery. Charac-
terisation of gp273 glycosylation could, therefore, provide the ﬁrst
clues as to their likely structures. Previous structural studies of
gp273 have been conﬁned to deﬁning its approximate molecular
weight by MALDI-MS (273 kDa) [43] and showing by MALDI-MS
and nuclear magnetic resonance (NMR) that its major N-glycans
are Glc1Man9GlcNAc2 and Man9GlcNAc2 [46]. Nothing has so far
been documented concerning its O-glycosylation other than the
aforementioned possibility that Lewisa-like structures are present.
Information on the nature of the O-glycome is now beginning to
emerge from our glycomic analyses exploiting high sensitivity
MALDI-TOF/TOF instrumentation and the GlycoWorkBench infor-
matics tool. This research is revealing that gp273 carries a diverse
repertoire of O-glycans, many of which are rich in fucose (Fuc).
This is illustrated by the MS and MS/MS data in Figs. 3 and 4,
respectively. As shown in the exemplar annotations in Fig. 3, the
GlycoWorkBench tool facilitates the assignment of possible sugar
compositions to each of the molecular ions in the MALDI-MS pro-
ﬁle. Putative compositions can then be ruled in or out by informa-
tion provided by MS/MS experiments. For example, the
GlycoWorkBench-annotated MS/MS data in Fig. 4 reveal that m/z
912 and 1680 have the compositions Hex2HexNAc1dHex1 and
Hex2HexNAc2dHex4, respectively, and not the other compositions
shown in Fig. 3. Note that the structures shown in the Fig. 4 anno-
tations take into account information from linkage analysis exper-
iments (data not shown) which deﬁned the types of
monosaccharides in the gp273 glycans. Signiﬁcantly the MS/MS
data showed unequivocally that the Fuc residues are mostly found
in the context of the blood group H-antigen. Work is in progress to
establish whether any Lewisa-like structures are actually present
in gp273.
1734 B. Tissot et al. / FEBS Letters 583 (2009) 1728–17354. Conclusion and future prospects
The advances in glycoproteomics over the past four decades
have been very signiﬁcant, in no small part due to key advances
in mass spectrometric instrumentation both with regard to ionisa-
tion techniques and instrument geometries, but also to the devel-
opment of strategies, both chemical and biochemical, for dealing
with complex glycoproteomic problems.
These advances, building upon the early concepts of biomolec-
ular mass spectrometric strategy and tactics, have been illustrated
in the present paper which outlines current glycoproteomic re-
search projects aimed at gaining a better understanding of the ﬁrst
stages of life itself, including sperm–egg binding. We have stressed
the important role of new glycoinformatic tools in this work, and
the further development of Cartoonist, GlycoWorkBench and other
similar software, together with the associated databases, will in fu-
ture provide a goldmine of expert interpretive knowledge available
to all. In summary, we can conclude that in perhaps only one or
two more decades at most, glycoproteomic analysis will be carried
out as effectively and efﬁciently and in as automated a fashion as is
currently achievable in the related ﬁeld of proteomics!
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